- Home
- XBIT vs NCSM Comparison
XBIT vs NCSM Comparison
Compare XBIT & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- NCSM
- Stock Information
- Founded
- XBIT 2005
- NCSM 2006
- Country
- XBIT United States
- NCSM United States
- Employees
- XBIT N/A
- NCSM N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- NCSM Oilfield Services/Equipment
- Sector
- XBIT Health Care
- NCSM Energy
- Exchange
- XBIT Nasdaq
- NCSM Nasdaq
- Market Cap
- XBIT 82.3M
- NCSM 94.0M
- IPO Year
- XBIT 2015
- NCSM 2017
- Fundamental
- Price
- XBIT $2.72
- NCSM $38.09
- Analyst Decision
- XBIT
- NCSM
- Analyst Count
- XBIT 0
- NCSM 0
- Target Price
- XBIT N/A
- NCSM N/A
- AVG Volume (30 Days)
- XBIT 175.4K
- NCSM 14.1K
- Earning Date
- XBIT 11-10-2025
- NCSM 10-29-2025
- Dividend Yield
- XBIT N/A
- NCSM N/A
- EPS Growth
- XBIT N/A
- NCSM N/A
- EPS
- XBIT N/A
- NCSM 4.53
- Revenue
- XBIT N/A
- NCSM $178,000,000.00
- Revenue This Year
- XBIT N/A
- NCSM $11.91
- Revenue Next Year
- XBIT N/A
- NCSM $7.63
- P/E Ratio
- XBIT N/A
- NCSM $8.25
- Revenue Growth
- XBIT N/A
- NCSM 16.49
- 52 Week Low
- XBIT $2.09
- NCSM $20.00
- 52 Week High
- XBIT $7.74
- NCSM $53.69
- Technical
- Relative Strength Index (RSI)
- XBIT 57.03
- NCSM 45.71
- Support Level
- XBIT $2.09
- NCSM $36.59
- Resistance Level
- XBIT $3.44
- NCSM $41.75
- Average True Range (ATR)
- XBIT 0.20
- NCSM 2.79
- MACD
- XBIT 0.06
- NCSM -0.13
- Stochastic Oscillator
- XBIT 46.67
- NCSM 41.22
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.